Functional expression of 5-HT2A receptor in osteoblastic MC3T3-E1 cells

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 278-282

  Hirai, Takao ^a   Kaneshige, Kota ^a   Kurosaki, Teruko ^a   Nishio, Hiroaki ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

5 HT; 5 HT specific transporter; 5 HT2A receptor; ERK; MC3T3 E1 cells; Signal transduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMPHETAMINES; ANIMALS; CELL LINE; CELL PROLIFERATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; PHOSPHORYLATION; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGONISTS;

EID: 77952743573     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.078     Document Type: Article

References (33)

1. Slominski A., Pisarchik A., Semak I., Sweatman T., Worstman J., Szczesniewski A., Slugocki G., McNulty J., Kauser S., and Tobin D.J. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J. 16 (2002) 896-898
2. 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain. Neurochem. Int. 47 (2005) 394-400
3. 1B receptors coupled to a Gi-protein. Nature 335 (1988) 254-256
4. Fanburg B.L., and Lee S.L. A new role for an old molecule: serotonin as a mitogen. Am. J. Physiol. 272 (1988) 795-806
5. Sharma S.K., Zahradka P., Chapman D., Kumamoto H., Takeda N., and Dhalla N.S. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J. Pharmacol. Exp. Ther. 290 (1999) 1475-1481
6. 2A receptor. Am. J. Physiol. 268 (1995) 122-127
7. 2A receptor coupled to the Jak/STAT pathway. J. Biol. Chem. 272 (1997) 14825-14829
8. 2A receptor. Ann. NY Acad. Sci. 861 (1998) 162-168
9. Canalis E. Growth factors, bone metabolism, and metabolic bone diseases. Endocrinologist 6 (1996) 89-94
10. Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2000) 1508-1514
11. Kondo A., and Togari A. Activation of osteoblastic functions by a mediator of pain, bradykinin. Biochem. Pharmacol. 68 (2004) 1423-1431
12. Suzuki A., Palmer G., Bonjour J.P., and Caverzasio J. Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology 140 (1999) 3177-3182
13. Bowler W.B., Buckley K.A., Gartland A., Hipskind R.A., Bilbe G., and Gallagher J.A. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone 28 (2001) 507-512
14. Warden S.J., Robling A.G., Haney E.M., Turner C.H., and Bliziotes M.M. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone 23 (2009) 4-12
15. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schütz G., Glorieux F.H., Chiang C.Y., Zajac J.D., Insogna K.L., Mann J.J., Hen R., Ducy P., and Karsenty G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135 (2008) 825-837
16. Battaglino R., Fu J., Spate U., Ersoy U., Joe M., Sedaghat L., and Stashenko P. Serotonin regulates osteoclast differentiation through its transporter. J. Bone Miner. Res. 19 (2004) 1420-1431
17. Bliziotes M.M., Eshleman A.J., Zhang X.W., and Wiren K.M. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29 (2001) 477-486
18. Westbroek I., van derPlas A., de Rooij K.E., Klein-Nulend J., and Nijweide P.J. Expression of serotonin receptors in bone. J. Biol. Chem. 276 (2001) 28961-28968
19. Warden S.J., Robling A.G., Sanders M.S., Bliziotes M.M., and Turner C.H. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146 (2005) 685-693
20. Warden S.J., and Haney E.M. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. J. Musculoskelet. Neuronal Interact. 8 (2008) 121-132
21. Hirai T., Tokumo K., Tsuchiya D., and Nishio H. Expression of mRNA for 5-HT2 receptors and proteins related to inactivation of 5-HT in mouse osteoblasts. J. Pharmacol. Sci. 109 (2009) 319-323
22. Hirai T., Taniura H., Goto Y., Ogura M., Sng J.C., and Yoneda Y. Stimulation of ubiquitin-proteasome pathway through the expression of amidohydrolase for N-terminal asparagine (Ntan1) in cultured rat hippocampal neurons exposed to static magnetism. J. Neurochem. 96 (2006) 1519-1530
23. Fujita T., Meguro T., Fukuyama R., Nakamuta H., and Koida M. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J. Biol. Chem. 277 (2002) 22191-22200
24. Bliziotes M., Eshleman A., Burt-Pichat B., Zhang X.W., Hashimoto J., Wiren K., and Chenu C. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 39 (2006) 1313-1321
25. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273 (1998) 1839-1842
26. Graves J.D., Campbell J.S., and Krebs E.G. Protein serine/threonine kinases of the MAPK cascade. Ann. NY Acad. Sci. 766 (1995) 320-343
27. Sugden P.H., and Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 9 (1997) 337-351
28. Schaeffer H.J., and Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 19 (1999) 2435-2444
29. Siddhanti S.R., and Quarles L.D. Molecular to pharmacologic control of osteoblast proliferation and differentiation. J. Cell Biochem. 55 (1994) 310-320
30. Fujita T., Azuma Y., Fukuyama R., Hattori Y., Yoshida C., Koida M., Ogita K., and Komori T. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol. 166 (2004) 85-95
31. Lampasso J.D., Marzec N., Margarone III J., and Dziak R. Role of protein kinase C alpha in primary human osteoblast proliferation. J. Bone Miner. Res. 17 (2002) 1968-1976
32. Lai C.F., Chaudhary L., Fausto A., Halstead L.R., Ory D.S., Avioli L.V., and Cheng S.L. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J. Biol. Chem. 276 (2001) 14443-14450
33. Ge C., Xiao G., Jiang D., and Franceschi R.T. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 176 (2007) 709-718